In the present study we examined 33 German and 10 Cuban unrelated Wilson disease (WND) index patients and their relatives. The common His1069Gln mutation accounted for 42% of all WND chromosomes in the German series and the haplotype C was found to be highly predictive for this mutation. Six WND gene mutations have not been described previously and involved a splice site at intron 18 (3903 + del1G), a termination codon in the copper-binding region of exon 2 (Cys271X), and missense mutations in transmembrane region 2 (Gly710Ala), in transmembrane region 3 (Tyr741Cys), in the DKTGT motif (Thr1031Ile) and in the ATP loop region (Gly1176Arg). In 15 German WND index patients and three sibs both WND mutations could be determined and a genotype-phenotype correlation was attempted. Patients homozygous for the His1069Gln mutation showed almost the complete range of clinical presentations, and thus in our study this mutation is not associated with a late, neurological presentation.
Introduction
Copper is an essential trace element in procaryotic and eukaryotic cells where many enzymes such as superoxide dismutase, cytochrome C oxidase, dopaminehydroxylase require its specific oxidative capacity to perform their normal biological roles. However, accumulation of copper can induce the production of highly reactive free radicals with concomitant damage to plasma membranes, peroxisomes, mitochondria, microtubules, enzymes and DNA. Two human genetic disorders, autosomal recessive Wilson disease (WND) effects on blood, bones, heart, and connective tissue. The prevalence of WND is estimated worldwide between 1/35 000 and 1/100 000 live births. 3 The pathological features result from the toxic accumulation of copper mainly in the liver, brain and kidneys, due to a failure of copper secretion from the liver to the bile, and a defective incorporation of copper into ceruloplasmin. Sudden death from haemolytic crisis or liver failure, or lifelong neurological disability can occur when the disease is identified too late for the appropriate removal of copper by chelating agents such as D-penicillamine and trien or by competitive inhibition through oral zinc. 4 The identification of the WND gene, ATP7B, 5, 6 a P-type copper-transporting ATPase with a predicted length of 1465 amino-acids, 7 made the comparison of different point mutations with differing clinical presentations possible. 5, [8] [9] [10] [11] [12] [13] [14] ATP7B consists of 21 exons which span a genomic region of about 80 kb. [5] [6] [7] [8] 15 In an effort to increase the number of molecularly characterised patients and to aid in genotype-phenotype correlation analysis we endeavoured to characterise WND patients from ethnically different populations and performed molecular analyses in 33 German and 10 Cuban WND index patients and relatives. For haplotype analysis the microsatellites D13S314, D13S301 and D13S316 were chosen, which span the ATP7B region on chromosome 13q14.3 and have been used previously by Thomas et al. 16 SSCP analysis and subsequent PCR-sequencing were performed to complete the molecular characterisation.
Patients and Methods

Patients
Molecular analysis was performed on 22 German index WND patients with cooperative relatives (43 parents, 10 grandparents, 2 spouses, 3 offsprings, 27 siblings), on 11 German index WND patients without cooperative relatives, and on 10 Cuban index WND patients (with 20 parents and 12 siblings). Index patients were characterised by H Hefter and W Stremmel at the Department of Neurology and Gastroenterology of the University Hospital, Düsseldorf, and by C Castañedo-Guillot at the Department of Pediatric Gastroenterology of the Instituto National de Gastroenterologia, Havanna. The diagnosis of Wilson disease was based on low ceruloplasmin and copper serum concentrations, increased urinary copper excretion, and a high liver copper concentration in each patient. Some details on the clinical investigations have been described elsewhere. [17] [18] [19] Whole venous blood was taken into EDTA and DNA-extracted by a saltprecipitation method (Nucleon II kit, Scotlab®).
Haplotype Analysis
The three microsatellite markers D13S314, D13S301, and D13S316 flanking the WND locus, which have been shown to correlate well with different mutations by Thomas et al, 16 were genotyped in index patients and available relatives and the segregation in haplotypes was established. Absolute allele sizes were determined by comparison with the known sequence of ATP7B exon 10 PCR product. 20 The PCR band were visualised by silver staining. 21 5 µl of each PCR product exhibiting a SSCP shift were enzymatically pretreated with exonuclease I (10 units) and shrimp alkaline phosphatase (2 units) for 15 min at 37°C, followed by an inactivation of these enzymes for 15 min at 80°C. The PCR samples were then ready for direct sequencing by the dideoxy chaintermination method with 35 S-dATP (5 µCi) (USB, Amersham LIFE SCIENCE) in both directions using the PCR primers again.
Detection of Mutations
Results
Haplotype Analysis
Twenty-four different haplotypes inherited on WND chromosomes were observed in the 22 German index patients with cooperative relatives where phase could be established, and an additional 11 haplotypes in the 10 Cuban index patients. The nomenclature of the haplotypes was as defined by Thomas et al, 16 and new haplotypes in our study were named 'O' to 'U'.
One haplotype occured in 36% of the German series, and was identical with the group C haplotype described by Thomas et al 16 (see Table 1 ). In four cases asymptomatic sibs showed the same haplotypes as the index patients. In two of these individuals a low level of serum ceruloplasmin was confirmed on preliminary clinical analysis consistent with the subclinical presence of Wilson disease.
The haplotype R was observed in three of the ten Cuban index patients, but also on one normal chromosome. The haplotype U was found in two Cuban patients and one German patient, and was not detectable on 82 normal chromosomes (see Table 1 ). Only C and U haplotypes were shared among German and Cuban patients, reflecting the importance of de novo mutations and ethnic differences.
Mutation Screening
The nomenclature of the mutations identified in this study is defined in Genbank for the mRNA sequence (Acc. No: U03464) and protein sequence (Acc. No.: 1947035), or Swiss-Protein (Acc. No: P35670).
Nine mutations in ATP7B were observed, six of which were novel and three of which had been previously described (His1069Gln and 340delC, Tanzi et al; 5 2531delA, Figus et al 10 ) . The novel WND mutations include one splice site alteration 3903 + del1G, which deletes the highly conserved guanin-nucleotide at position one in the 5' splice site of intron 18, one nonsense mutation Cys271X leading to a premature termination of translation in exon 2 in two sibs (see Figure 1 ), and missense mutations Tyr741Cys, Thr1031Ile, Gly1176Arg and Gly710Ala (also mutated as Gly710Ser, Waldenström et al 11 ). In the German series the His1069Gln (previously His1070Gln) mutation predominated (28 of 66 WND chromosomes, ie about 42%). This common mutation is easily detectable as a shift in SSCP analysis (see Figure 2) . The mutations His1069Gln and 3400delC (previously 3403delC) were also observed among the 20 Cuban WND chromosomes (see Table 1 and 2), although in the case of 3400delC it was a modified haplotype.
From the German series of 33 index patients we could identify the mutations of both alleles in 15 index patients, of one allele in 12 index patients (7 of whom were heterozygous for the His1069Gln mutation); both mutations of 6 index patients are still unknown. In the Cuban series of 10 index patients we could verify the mutations of one allele in only 3 patients; the others were not detectable.
Eight changes in the known sequence of ATP7B were identified, which do not modify the amino acid sequence of the gene product or are conservative changes in non-vital residues (see Table 2 ). These sequence variants were considered as DNA polymorphisms, some were also reported in other studies. 8, 10 Haplotype-mutation Correlation Seven out of the nine mutations detected could be correlated to certain haplotypes (see Table 1 ). The two remaining mutations were found in single WND patients without cooperative relatives, in which haplotypes could not be established. In the German series the haplotype C was highly predictive for WND
Figure 1 Identification of the C271X mutation in exon 2 sequenced with the downstream primer 2e (see Patients and Methods). 1 N 2 indicates as WD9-1 ( = 1), normal individual ( = N), WD9-2 patient ( = 2), respectively. The arrows point to the mutated bases.
Figure 2 SSCP analysis of His1069Gln mutation in exon 14 of the ATP7B gene. Probands 1-4 are a family; probands 5-8 are other unrelated WND patients. The homozygous index patient is indicated by a black pedigree symbol, his heterozygous parents are shaded. In addition to the normal SSCP band (N), a lower band (WND) shows the mobility shift representing the His1069Gln mutation.
Wilson mutations Duc Ha-Hao et al t chromosomes and for the His1069Gln mutation. In the Cuban WND series this haplotype was rare and was also present on one normal chromosome (see Table 1 ). The His1069Gln mutation was also associated with three other haplotypes (see Table 1 ), which were rare (found on 1, 1, 2 WND chromosomes, respectively) and much more nonspecific (found on 1, 1, 3 normal chromosomes as well). The mutation 3400delA was associated with haplotype O in German and Cuban patients. Neither variant of this haplotype O was found on normal chromosomes and thus it seemed to be specific for this mutation. All other mutations and haplotypes were too rare or were also detected on normal chromosomes for firm conclusions on their specificity.
Genotype-phenotype Correlation
WND The comparison of patients with identical homozygous or heterozygous constellations and in particular of sibs with identical WND genotype permits estimation of the dependence of the phenotype on additional genetic or environmental factors. In 15 index patients plus three sibs of the German series the mutations on both of their WND chromosomes could be identified (see Table 3 ).
The patient WD1 was homozygous for the missense mutation Gly710Ala, whose glycine to alanine substitution within transmembrane helix 2 is likely to result in a minor change. This patient showed a late and mild hepatic presentation with normal serum ceruloplasmin (19.5 mg/dl).
Seven index patients and one sib, WD2 to WD8, were homozygous for the most common mutation, His1069Gln. These patients exhibited a wide range of clinical presentation, as previously observed by Thomas et al 8 Two of them, WD3 and WD7-1, have the hepatic form of disease, but with considerable difference in age at onset (5 years and 24 years, respectively). Four index patients, WD2, WD4, WD5, WD6 and the sib WD7-2 have the neurologic form, with the age at onset ranging from 19 to 35 years. Patient WD8 has the hepatic/ neurologic phenotype with an age of onset at 12 years.
The nine German patients WD9-1 to WD15-2 could be demonstrated to be compound heterozygotes of different WND mutations. All of them carried the His1069Gln mutation plus a variable second WND mutation. The patients WD9-1 and WD9-2 were sibs and had the genotype His1069Gln combined with Cys271X. Both patients were subjectively asymptomatic and were diagnosed by a routine blood transaminase assessment. The combination of His1069Gln with 3400delC was observed in the two unrelated patients WD12 and WD13, who both presented with similar neurological symptoms at nearly identical ages. Sibs WD15-1 and WD15-2 had the combination of two missense mutations, His1069Gln with Gly1176Arg, and again both presented with similarly mild hepatic symptoms at around 12 years of age. 
In Table 4 we have distinguished the German series by three genotype groups -the homozygous index patients for His1069Gln, the heterozygous index patients for His1069Gln, and the index patients with other mutations on both alleles. Patients who were homozygous for His1069Gln mutation were on average older at the age of onset (18.7 years) than were compound heterozygous (16.4 years) and patients with other mutations (18.0 years). Moreover, females seemed to predominate in this homozygous group (6:1) in comparison with the heterozygous group (5:9).
Discussion
In this study of 33 German and 10 Cuban unrelated Wilson disease patients, we identified the mutation on 47 WND chromosomes (55%). This is in good agreement with other studies using SSCP-based mutation analysis. 8, 10, 13 Since WND locus homogeneity in the ATP7B region has been shown by multipoint linkage analysis of Wilson patients with widely differing clinical presentations, 6, 15 almost half of WND mutations remained undetected by the methods used or may lie outside the coding region, possibly in the regulatory regions. In agreement with other European studies the His1069Gln mutation predominates by far and accounts for 42% of German WND chromosomes. Because of the importance of this mutation we developed an SSCP system to facilitate its detection (see Patients and Methods), which would be an equivalent alternative to the previously described PCR diagnosis. 22 The investigation of His1069Gln in different ethnic groups underlines the predominance of this mutation for Wilson disease particularly in Central Europe, with frequencies of 61% among Austrian, 22 Wilson mutations Duc Ha-Hao et al t the haplotype C is highly predictive for the mutation among Germans. Our observation of four different haplotypes associated with the His1069Gln mutation could be due to at least two independent historic events or to microsatellite slippage.
In 7 German index patients and one sib the His1069Gln mutation was observed in a homozygous state, but in contrast to Houwen et al 23 who found a late, neurological presentation in 10 homozygous His1069Gln patients, one patient in our sample developed hepatic symptoms at 5 years of age, and two more patients at 12 and 24 years. The His1069Gln homozygotes showed early and severe hepatic manifestations as well as a case of mild neurological presentation at age 30. On the whole we observed no significant difference in clinical picture between Wilson patients world-wide (where about three-quarters present with neurological symptoms at an average age of 20 years 1 ), our German Wilson disease population and this homozygous His1069Gln sample. Similar observations were also noted in an Austrian study, where seven of 15 homozygous patients with His1069Gln mutation presented with liver disease, 22 and in a North American study, where ten of 20 homozygous patients had hepatic presentation. 13 It seems, therefore, that the His1069Gln mutation is permissive for a wide range of Wilson phenotypes, which are determined by additional factors.
The observed uneven distribution of the His1069Gln mutation according to sex in homozygotes indicates that female sex hormones could influence the clinical manifestation. 22 
